期刊文献+

血清C肽水平变化与2型糖尿病微血管病变的相关性研究 被引量:19

The relationship of serum C-peptide levels and microvascular complications in type 2diabetes mellitus
原文传递
导出
摘要 目的:探讨T2DM 患者血清C‐P水平变化与微血管病变的关系。方法回顾性分析434例T2DM患者的临床资料,根据ΔC‐P(2 hC‐P -FC‐P)的三分位数由低到高分为ΔC‐P1(≤2.2 ng/ml)、ΔC‐P2(2.3~4.0 ng/ml)和ΔC‐P3(≥4.1 ng/ml)。结果ΔC‐P1组BMI、TG、FC‐P水平较低,病程、HbA1c水平较高(P<0.05)。血清ΔC‐P水平与BMI、TG水平呈正相关(P<0.05),与DR、糖尿病慢性肾脏疾病(CKD)发病率、病程、HbA1c水平呈负相关(P<0.05)。随DR和CKD的进展,ΔC‐P水平逐渐降低。Logistic回归分析显示,在校正相关因素后,较低水平的ΔC‐P是发生微血管并发症的独立危险因素。结论血清ΔC‐P水平是T2DM 微血管并发症的独立相关因素。 Objective To evaluate the relationship between serum C‐P levels and microvascular complications in patients with T 2DM. Methods The clinical data of 434 patients with T2DM were retrospectively analyzed. All subjects were divided into three groups based on ΔC‐P (2 hC‐P - FC‐P) tertiles :ΔC‐P1(≤2.2 ng/ml) ,ΔC‐P2(2.3~4.0 ng/ml) and ΔC‐P3(≥4.1 ng/ml). Results The levels of BMI ,TG ,FC‐P were lower ,and the course and HbAl c were higher in ΔC‐P1 group. ΔC‐P level was positively associated with BMI and TG (P〈0.05) ,and negatively associated with prevalence of DR and chronic kidney disease (CKD)in diabetes ,course and HbA1 c.ΔC‐P levels decreased gradually with the progression of DR and CKD. Logistic regression analysis showed that lower ΔC‐P level was the independent risk factor for microvascular complications after adjustment for related risk factors. Conclusion Serum ΔC‐P level is an independent factor for the development of diabetic microvasculr complications in T 2DM.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第5期430-433,共4页 Chinese Journal of Diabetes
关键词 糖尿病 2型 糖尿病慢性肾脏疾病 糖尿病视网膜病变 C肽 Diabetes mellitus, type 2 Chronic kidney disease (CKD) in diabetes Diabeticretinopathy tDR) C-peptide(C-P)
  • 相关文献

参考文献10

  • 1李桂芹,杨金奎,李明珠.不同病程中C-肽与2型糖尿病微血管病变的相关性[J].中国微循环,2009,13(1):38-41. 被引量:16
  • 2张东铭,钱镭,付艳芹,辛雅萍,张苏河.C肽对2型糖尿病视网膜病变的保护作用及机制[J].中国实用神经疾病杂志,2011,14(15):43-45. 被引量:7
  • 3Kim BY, Jung CH, Mok JO, et al. Associ:ation between serum C-peptide levels and chronic rnierovascular complications in Ko- rean type 2 diabetic patients. Acta Diabetologica, 2012, 49: 9-15.
  • 4Paterson AD, Rutled BN, Cleary PA, et al. The effect of inten- sive diabetes treatment on resting heart rate in type 1 diabetes: the diabetes control and complications trial/epidemiology of di- abetes interventions and eomplicationsstudy. Diabetes Care, 2007,30 : 2107-2112.
  • 5Steffes MW,Sibley S,Jackson M,et al. B-cell function and the.development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care, 2003, 26: 832-836.
  • 6No S,Gentile L, Castiglione A, et al. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol, 2012,167: 173-180.
  • 7潘斌斌,苏晓飞,马建华,郭琳,丁波,孙睿,罗勇,徐小华.血清C肽与2型糖尿病患者血糖控制及并发症的关系分析[J].中华内分泌代谢杂志,2013,29(5):380-382. 被引量:31
  • 8陈晓蕾,宋滇平,罗平.2型糖尿病患者血清C肽水平与尿白蛋白肌酐比及神经传导速度的关系[J].中国糖尿病杂志,2008,16(6):334-337. 被引量:9
  • 9Bhatt MP, Lim YC, Hwang J, et al. C-peptide prevents hyper- glycemia-induced endothelial apoptosis through inhibition of re- active oxygen species-mediated transglutaminase 2 activation. Diabetes, 2013,62 : 243-253.
  • 10Nordquist L,Brown R,Fasching A, et al. ProInsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorp- tion. Am J Physiol Renal Physiol, 2009,297 : 1265-1272.

二级参考文献33

  • 1钱镭,张苏河,潘伟杰,常卫华,王一浩.C肽及其类似物对1型糖尿病患者红细胞膜ATP酶的影响[J].郑州大学学报(医学版),2005,40(6):1093-1096. 被引量:1
  • 2Johansson BL, Kernell A, Sjoberg S,et al. Inffluence of combined cpeptide and insulin administration on renal function and metabolic control in diabetes type 1 [ J]. J Clin Endoerinol Metab, 1993, 77: 976 - 981
  • 3Samnegard B, Jacobson SH, Jaremko G, et al. C-peptide prevents glomerular hypertrophy and mesangial matrix in diabetic rats [ J ]. Nephrol Dial Transplant, 2005,20 : 532 - 538
  • 4Ido Y, Vindigni A , Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[ J]. Science, 1997, 277 (5325) :563-566
  • 5Sari R,Balsi MK. Relationship between C-peptide and chronic complications in type-2 diabetes mellitus. Journal of the National Medical Association[ J]. 2005,97 : 1113 - 1118
  • 6Tsimaratos M, Roger F, Chabardes D, et al. C-peptide stimulates Na^+-K^+-ATPase activity via PKC alpha in rat medullary thick ascending limb[ J]. Diabetologia, 2003, 46( 1 ) : 124 - 131
  • 7Sima AA, Zhang W, Grunberger G. Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res[J]. 2004,5(1 ) :65-77
  • 8Motala AA, Pirie FJ, Gouws E, et al. Microvascular complications in South African patients with long-duration diabetes mellitus [ J ]. S AfrMed J, 2001,91 : 987 -992
  • 9Dyck PJ , Davies JL , Wilson DM , et al. Risk factors for severity of diabetic polyneuropathy : intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort [ J]. Diabetes Care, 1999, 22 : 1479 - 1486
  • 10Marques RG, Fontaine MJ, Rogers J. C-peptide: much more than a byproduct of insulin biosynthesis[J].Pancreas, 2004,29 (3) 231-238.

共引文献55

同被引文献151

引证文献19

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部